Therapy with interleukin-2 and tumor-derived activated lymphocytes
Oldham, R.K.
Immunology Series 61: 251-271
1994
ISSN/ISBN: 0092-6019 PMID: 8011748 Document Number: 426962
Document emailed within 1 workday
Related Documents
Itoh, K.; Shiiba, K.; Ebina, N.; Anzai, R.; Ouchi, A.; Matsuno, S. 1993: Functional and phenotypic analysis of tumor infiltrating lymphocytes derived from solid tumors and effusion associated lymphocytes in malignant ascites cultured in recombinant interleukin 2 Nihon Geka Gakkai Zasshi 94(8): 781-790Kierszenbaum, F.; Lopez, H.M.; Sztein, M.B. 1996: Trypanosoma cruzi downregulates the production of interleukin-2, interferon-gamma, interleukin-4 and interleukin-5 by activated human lymphocytes Journal of Parasitology 82(4): 652-656
Takahashi, M. 1991: Specific antitumor effect of lymphokine-activated lymphocytes obtained from tumor-bearing mice after intratumoral injection of interleukin-2 (IL-2) Nihon Geka Gakkai Zasshi 92(3): 247-256
Lamers, H.J.; Gratama, J.W.; van Putten, W.L.; Stoter, G.; Bolhuis, R.L. 1991: Exogenous interleukin 2 recruits in vitro lymphokine-activated killer activity by in vivo activated lymphocytes Cancer Research 51(9): 2324-2328
Bellamy, A.S.; Calder, V.L.; Feldmann, M.; Davison, A.N. 1985: The distribution of interleukin-2 receptor bearing lymphocytes in multiple sclerosis: evidence for a key role of activated lymphocytes Clinical and Experimental Immunology 61(2): 248-256
Sun, A.; Chu, C.T.; Liu, B.Y.; Wang, J.T.; Leu, J.S.; Chiang, C.P. 2000: Expression of interleukin-2 receptor by activated peripheral blood lymphocytes upregulated by the plasma level of interleukin-2 in patients with recurrent aphthous ulcers Proceedings of the National Science Council Republic of China. Part B Life Sciences 24(3): 116-122
Yoshizawa, H.; Chang, A.E.; Shu, S.Y. 1992: Cellular interactions in effector cell generation and tumor regression mediated by anti-CD3/interleukin 2-activated tumor-draining lymph node cells Cancer Research 52(5): 1129-1136
Savary, C.A.; Lotzová, E. 1990: Inhibition of human bone marrow and myeloid progenitors by interleukin 2-activated lymphocytes Experimental Hematology 18(10): 1083-1089
Blacklock, J.B.; Grimm, E.A. 1989: Lymphokine-activated killer lymphocytes: LAK and interleukin-2 in the treatment of malignancies of the central nervous system Immunology Series 48: 93-99
Raghu, G.; Park, S.W.; Roninson, I.B.; Mechetner, E.B. 1996: Monoclonal antibodies against P-glycoprotein, an MDR1 gene product, inhibit interleukin-2 release from PHA-activated lymphocytes Experimental Hematology 24(10): 1258-1264
Nagao, N.; Katoh, M.; Kumazawa, I.; Tomita, H.; Sugiyama, Y.; Kunieda, K.; Miya, K.; Saji, S. 1999: A recurrent case of esophageal cancer in which metastatic skin tumor disappeared after local injection of activated lymphocytes with tumor-pulsed dendritic cells Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(12): 1937-1939
Damle, N.K.; Doyle, L.V.; Bender, J.R.; Bradley, E.C. 1987: Interleukin 2-activated human lymphocytes exhibit enhanced adhesion to normal vascular endothelial cells and cause their lysis Journal of Immunology 138(6): 1779-1785
Ryffel, B.; Müller, S.; Foxwell, B. 1987: Cyclosporine a allows the expression of high affinity interleukin 2 binding sites on anti-T-cell antibody activated human T lymphocytes Transplantation Proceedings 19(1 Part 2): 1199-1201
Morisaki, T.; Matsumoto, K.; Kuroki, H.; Kubo, M.; Baba, E.; Onishi, H.; Tasaki, A.; Nakamura, M.; Inaba, S.; Katano, M. 2003: Combined immunotherapy with intracavital injection of activated lymphocytes, monocyte-derived dendritic cells and low-dose OK-432 in patients with malignant effusion Anticancer Research 23(6a): 4459-4465
Gotoh, Y.I.; Minegishi, M.; Yamaguchi, Y.; Konno, T.; Tada, K. 1984: Interleukin-2 activated peripheral blood lymphocytes and the correlation of lytic activity and peanut agglutinin receptor expression on malignant cells Clinical and Experimental Immunology 57(3): 710-716
Li, B.; Yue, Y.; Dong, C.; Shi, Y.; Xiong, S. 2014: Blockade of macrophage autophagy ameliorates activated lymphocytes-derived DNA induced murine lupus possibly via inhibition of proinflammatory cytokine production Clinical and Experimental Rheumatology 32(5): 705-714
Morita, T.; Yonese, Y.; Minato, N. 1987: In vivo distribution of recombinant interleukin-2-activated autologous lymphocytes administered by intra-arterial infusion in patients with renal cell carcinoma Journal of the National Cancer Institute 78(3): 441-450
Röllinghoff, M.; Wagner, H. 1974: Activated T-lymphocytes--a mode of physiological tumor defence Verhandlungen der Deutschen Gesellschaft für Innere Medizin 80: 1584-1586
Itoh, K.; Tilden, A.B.; Kumagai, K.; Balch, C.M. 1985: Leu-11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL 2)-induced activated killer (AK) cells Journal of Immunology 134(2): 802-807
Remick, D.G.; Scales, W.E.; May, M.A.; Spengler, M.; Nguyen, D.; Kunkel, S.L. 1988: In situ hybridization analysis of macrophage-derived tumor necrosis factor and interleukin-1 mRNA Laboratory Investigation; a Journal of Technical Methods and Pathology 59(6): 809-816